Publication | Closed Access

Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial

RheumatologyAutoimmune DiseaseMedicineSystemic TreatmentImmunologyClinical TrialsClinical DermatologyPlacebo-controlled TrialPharmacotherapySevere Plaque-type PsoriasisDermatologyImmunotherapyPsoriatic ArthritisInfliximab Induction Therapy